J
JD Health
Health Tech & Medtech · Dongcheng District, China · Founded 2019
Is an e-commerce platform for pharmaceutical products such as vitamins & supplements (subsidiary of JD.com) MoreLess
JD Health stands as the healthcare-centric subsidiary of Chinese e-commerce corporation JD.com. The journey began in 2014 when JD.com's healthcare operations started as a distinct business unit. The entity was formally launched as JD Health in 2017 and commenced independent operations in May 2019. A significant milestone was achieved in December 2020 with its successful listing on the Hong Kong Stock Exchange, which raised approximately $3.5 billion.
Initially led by CEO Lijun Xin, who was instrumental in building the business from its inception, the leadership transitioned in September 2021. Jin Enlin, who joined JD.com in 2014 and has extensive experience in the medical and TMT sectors, was appointed as the new CEO. The company is chaired by Liu Qiangdong, the founder of JD.com.
JD Health's business model is multifaceted, operating across B2C, B2B, and O2O channels. A primary revenue stream is its retail pharmacy business, which includes both direct sales and a third-party marketplace. This platform offers a vast selection of pharmaceuticals, healthcare products, medical devices, and nutritional supplements. Leveraging JD.com's formidable supply chain, the company provides efficient delivery, including a 30-minute option in many cities through partnerships with over 200,000 offline pharmacies. The online healthcare services segment represents another core component of its operations. This includes telemedicine consultations with a network of over 130,000 doctors and medical professionals. During the COVID-19 pandemic, daily online consultations surged, reaching over 100,000. The company serves individual consumers, corporate clients, and medical institutions. It also provides digital solutions for corporations and insurance companies.
The company's offerings are designed to cover the entire lifecycle of a user's health needs. Services include online appointments for health check-ups, vaccinations, and medical cosmetology. JD Health has also established 16 specialized online medical centers focusing on areas like respiratory health and diabetes. Furthermore, it has developed intelligent hospital solutions and is a significant retailer of Food for Special Medical Purposes (FSMP). The company continually integrates technology, such as AI-driven customer service and data analytics, to enhance its services and personalize the user experience.
Keywords: online healthcare, digital health, e-pharmacy, telemedicine, pharmaceutical retail, healthcare supply chain, B2C healthcare, O2O medical services, medical consultations, health management platform, China healthcare, online pharmacy, digital hospital, consumer healthcare, medical e-commerce, chronic disease management, health technology, Food for Special Medical Purposes, online doctor, pharmaceutical delivery
Company overview
JD Health company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Dongcheng District, China
- Employees
- —
- Open positions
- None listed
- Dealroom signal
- 24.7
- Investment activity
- 1 companies · latest Aug 2021
- Capital deployed
- $93M
- Preferred round
- SERIES D
Valuation & funding
JD Health funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| IPOOther financing | Dec 2020 | $3.5B | $29B | Undisclosed | — |
| SERIES BOther financing | Aug 2020 | $830M | $7B | Hillhouse Capital | — |
| SERIES AOther financing | May 2019 | $1B | $7B | CICC · JD.com · Baring Private Equity Asia | ↗ |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $10B | 0% | $889M | 8.8% |
| 2025 | $10B | +26.3% | $889M | 8.8% |
| 2024 | $8B | +8.6% | $734M | 9.2% |
| 2023 | $7.4B | +14.5% | $413M | 5.6% |
| 2022 | $6.4B | +52.3% | $130M | 2% |
| 2021 | $4.2B | +58.3% | −$109M | -2.6% |
| 2020 | $2.7B | — | −$2.3B | -87.9% |
Growth signals
JD Health website traffic
Latest recorded traffic for JD Health is 630 monthly website visits, down 87.6% over the last three months.
Comparisons
JD Health compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
JD Health investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
JD Health's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where JD Health has talent and traffic
In the news
Latest news about JD Health
Recent press, funding announcements, and product moves mentioning JD Health — open to read from the original sources.
Market sentiment
What the market is saying about JD Health
An AI-synthesized read of the highest-engagement posts about JD Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See JD Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.